arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Nu Skin Enterprises, Inc.

NUS Health Care Other Pharmaceuticals
$4.92
▼ -1.2% Today
as of Oct 22, 16:51 ET
Last 30 days +1.03% Sep 14 → Oct 22
$4.48 $4.67 $4.87 $5.07 $5.26 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$4.86
High
$4.97
Low
$4.70
Volume
$271,296
Avg Vol
$556,195
Mkt Cap
$234M
P/E (TTM)
—
Beta
—
52w High
$11.67
52w Low
$4.45
Div Yield
—
Shares Out
—

NUS earnings at a glance

Nu Skin Enterprises, Inc. (NUS) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of $0.21, compared with $0.34 in the same quarter last year (-38%). The options market is pricing a move of about ±9.4% after the report, a range of roughly $4.46 to $5.38 from today's $4.92. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±10.2% on average; after the most recent report on Aug 10, 2026 it moved -5.4%. That means options currently expect about the same movement than NUS has typically delivered. NUS beat the consensus EPS estimate in 3 of its last 6 reported quarters. Implied volatility is currently 75%. The share price of $4.92 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$4.45
$12
7% of range
Avg surprise (last 6)
+21.4%
Avg reaction (last 6)
-2.9%
50% positive
Latest IV / EM
75%
EM ±9.4% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.38$-1.65$-0.92$-0.19$0.54 Actual $0.23Actual $0.54Actual $-0.74Actual $-0.01Actual $-2.38Actual $0.17Actual $0.23Est $0.15Actual $0.43Est $0.25Actual $0.34Est $0.30Actual $0.29Est $0.30Actual $0.14Est $0.15Actual $0.20Est $0.20 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-250M$-74M$101M$276M$452M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon Aug 10, 2026Jun/2026 $0.20 $0.20 0.0% -53.5% -5.4% earnings
Thu May 7, 2026Mar/2026 $0.14 $0.15 -6.7% -39.1% +2.0% earnings
Thu Feb 12, 20268K 2026-02-12 $0.29 $0.30 -3.3% — -18.1% earnings
Thu Nov 6, 2025Sep/2025 $0.34 $0.30 +13.3% — -15.8% earnings
Thu Aug 7, 2025Jun/2025 $0.43 $0.25 +72.0% — +8.9% earnings
Thu May 8, 2025Mar/2025 $0.23 $0.15 +53.3% — +11.0% earnings
Mon Sep 30, 2024Sep 2024 $0.17 — — — — financials
Sun Jun 30, 2024Jun 2024 $-2.38 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.01 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.74 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.54 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.23 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER $0.21$0.34 -38.2%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$320M$321M—$364M$386M$364M—$430M
Cost of revenue$102M$106M—$107M$120M$118M—$129M
Gross profit$218M$214M—$257M$266M$247M—$301M
Operating income$-59M$4M—$22M$31M$-10M—$18M
Net income$-250M$2M—$17M$21M$108M—$8M
EPS (diluted)$-5.14$0.04—$0.34$0.43$2.14—$0.17

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$190M$199M$239M$252M$264M$204M$187M$228M
Inventory$191M$179M$179M$179M$180M$189M$190M$248M
Total current assets$508M$523M$548M$548M$572M$525M$539M$653M
Total assets$1.12B$1.38B$1.41B$1.42B$1.44B$1.39B$1.47B$1.58B
Long-term debt$194M$204M$204M$209M$214M$219M$364M$373M
Total liabilities$579M$583M$600M$625M$656M$637M$817M$876M
Total equity$543M$794M$805M$800M$788M$754M$651M$707M

Implied volatility — last 90 days

24%121%218%315%411% Jun 07 — IV 148% · EM ±20.5%Jun 08 — IV 135% · EM ±17.9%Jun 09 — IV 139% · EM ±17.5%Jun 10 — IV 172% · EM ±20.3%Jun 11 — IV 175% · EM ±19.3%Jun 12 — IV 188% · EM ±19.2%Jun 15 — IV 105% · EM ±7.6%Jun 17 — IV 72% · EM ±3.0%Jun 19 — IV 54% · EM ±12.0%Jun 22 — IV 65% · EM ±13.5%Jun 23 — IV 66% · EM ±13.6%Jun 24 — IV 64% · EM ±12.7%Jun 29 — IV 70% · EM ±12.3%Jun 30 — IV 55% · EM ±9.5%Jul 02 — IV 31% · EM ±5.0%Jul 03 — IV 32% · EM ±5.0%Jul 06 — IV 43% · EM ±6.0%Jul 07 — IV 132% · EM ±17.4%Jul 08 — IV 39% · EM ±4.9%Jul 09 — IV 25% · EM ±2.9%Jul 13 — IV 182% · EM ±15.2%Jul 14 — IV 56% · EM ±4.0%Jul 20 — IV 103% · EM ±24.4%Jul 21 — IV 59% · EM ±13.8%Jul 22 — IV 69% · EM ±15.8%Jul 23 — IV 72% · EM ±16.2%Jul 24 — IV 69% · EM ±15.3%Jul 27 — IV 65% · EM ±13.6%Jul 28 — IV 72% · EM ±14.8%Jul 29 — IV 109% · EM ±21.7%Jul 30 — IV 66% · EM ±12.9%Jul 31 — IV 70% · EM ±13.5%Aug 03 — IV 82% · EM ±14.5%Aug 04 — IV 71% · EM ±12.2%Aug 05 — IV 75% · EM ±12.5%Aug 06 — IV 66% · EM ±10.6%Aug 07 — IV 94% · EM ±14.6%Aug 10 — IV 100% · EM ±13.9%Aug 11 — IV 78% · EM ±10.3%Aug 12 — IV 99% · EM ±12.4%Aug 13 — IV 79% · EM ±9.3%Aug 14 — IV 85% · EM ±9.4%Aug 17 — IV 192% · EM ±16.0%Aug 18 — IV 191% · EM ±13.8%Aug 19 — IV 124% · EM ±7.3%Aug 20 — IV 412% · EM ±17.2%Aug 24 — IV 53% · EM ±11.0%Aug 25 — IV 48% · EM ±9.8%Aug 26 — IV 49% · EM ±9.7%Aug 27 — IV 48% · EM ±9.4%Aug 28 — IV 46% · EM ±8.8%Aug 31 — IV 57% · EM ±10.1%Sep 01 — IV 114% · EM ±19.7%Sep 02 — IV 50% · EM ±8.3%Sep 03 — IV 62% · EM ±10.1%Sep 04 — IV 50% · EM ±7.7%Sep 07 — IV 56% · EM ±7.7%Sep 08 — IV 88% · EM ±11.6%Sep 09 — IV 91% · EM ±11.3%Sep 10 — IV 78% · EM ±9.2%Sep 11 — IV 61% · EM ±6.7%Sep 14 — IV 86% · EM ±7.2%Sep 15 — IV 160% · EM ±11.6%Sep 16 — IV 296% · EM ±17.5%Sep 17 — IV 390% · EM ±16.3%Sep 21 — IV 64% · EM ±13.4%Sep 22 — IV 60% · EM ±12.3%Sep 23 — IV 54% · EM ±10.8%Sep 24 — IV 99% · EM ±19.5%Sep 25 — IV 102% · EM ±19.4%Sep 28 — IV 109% · EM ±19.4%Sep 29 — IV 66% · EM ±11.4%Sep 30 — IV 112% · EM ±18.8%Oct 01 — IV 136% · EM ±22.0%Oct 02 — IV 125% · EM ±19.5%Oct 05 — IV 141% · EM ±19.5%Oct 06 — IV 128% · EM ±16.9%Oct 07 — IV 75% · EM ±9.4%

Sector peers

HWH
HWH International Inc.
$69M $2.68+15.0%
COSM
Cosmos Health Inc.
$39M $0.25-23.6%
SCNX
Scienture Holdings, Inc.
$7M $2.77-9.2%
WGRX
Wellgistics Health, Inc.
$7M $3.52
SNYR
Synergy CHC Corp.
$1M $0.090.0%
HLF
Herbalife Ltd.
$1.3B $13.78+0.1%

NUS earnings FAQ

When is NUS's next earnings date?

Nu Skin Enterprises, Inc. is expected to report on November 5, 2026.

What is NUS's expected move for earnings?

Options currently price a move of about ±9.4%, or $0.46 per share either way from $4.92.

How does NUS stock usually react to earnings?

Across the last 6 reports the average next-day move was ±10.2%, up 3 times and down 3 times.

What EPS are analysts expecting from Nu Skin Enterprises, Inc.?

The consensus estimate is $0.21 per share, versus $0.34 a year ago.

What is NUS's implied volatility?

NUS's at-the-money implied volatility is about 75% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in